论文部分内容阅读
目的:分析胺碘酮临床应用于心衰并发室性心律失常老年患者的治疗效果。方法:选取2012年1月至2014年1月该院的65例老年心衰合并心律失常患者来进行研究分析,为患者使用抗心衰治疗,并结合胺碘酮治疗,视情况进行点滴或肌注,记录患者治疗前后的心功能、心率、不良反应等指标进行比较分析。结果:经过治疗后,全部的患者中共有87.69%的心律失常症状得到了显著改善,其心率有所下降,临床中治疗前后差异显著(P<0.05);患者接受药物治疗后,共出现3例窦性心动过缓病例,停药或减量后患者可以缓解症状。结论:老年心衰合并室性心律失常患者使用抗心衰治疗和胺碘酮治疗具有比较好的效果,临床疗效突出,而且安全性有保障,值得推广使用。
Objective: To analyze the clinical effect of amiodarone in elderly patients with heart failure and ventricular arrhythmia. Methods: From January 2012 to January 2014, 65 elderly patients with heart failure and arrhythmia were enrolled in this study. The patients were treated with anti-heart failure and combined with amiodarone, Note, record the patients before and after treatment of heart function, heart rate, adverse reactions and other indicators for comparative analysis. Results: After treatment, a total of 87.69% of the patients with arrhythmia symptoms have been significantly improved, the heart rate decreased, the clinical significant difference before and after treatment (P <0.05); patients receiving drug treatment, a total of 3 cases Sinus bradycardia cases, withdrawal or reduction patients can relieve symptoms. Conclusion: Elderly patients with heart failure and ventricular arrhythmia using anti-heart failure treatment and amiodarone treatment has a good effect, clinical efficacy is outstanding, and the safety is guaranteed, it is worth to promote the use.